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Introduction
Autoinflammatory diseases are a group of disorders char-
acterized by seemingly unprovoked inflammation in the
absence of high-titer autoantibodies or antigen-specific
T-cells. Familial Mediterranean fever (FMF) is the arche-
typal hereditary periodic fever syndrome and autoinflam-
matory disorder. It is characterized by recurrent self-
limiting episodes of fever and painful polyserositis. FMF
is an autosomal recessive disorder, with considerable pre-
valence in specific ethnic groups, namely, non-Ashkenazi
Jews, Armenians, Turks and Arabs and the FMF carrier
rate can be as high as one in four. The gene responsible
for FMF, MEFV, is located on the short arm of human
chromosome 16, and was independently identified by two
positional cloning consortia. Mutations, as well as, poly-
morphisms in MEFV are continuously identified. In
Arabic FMF patients the spectrum and distribution of
MEFV mutations are distinctive and the portion of uni-
dentified mutations is undoubtedly the highest amongst
the groups commonly affected by FMF. The comprehen-
sive identification of MEFV mutant alleles among FMF
patients is needed for the efficient examination of specific
genotype – phenotype correlation patterns and for the
development of molecular tools to support the clinical
diagnosis.
Objectives
To identify MEFV mutations in a cohort of Arabic
patients using a comprehensive approach that could
identify coding and non-coding variations, large duplica-
tions or deletions, as well as intronic variations.
Methods
We obtained 100 patients of Palestinian origin with
clear FMF symptomatology consistent with the clinical
diagnostic criteria and for whom only one mutation has
been identified. We applied a comprehensive mutation
analysis approach that involves sequencing of exons and
splice sites, sequencing putative regulatory regions, Mul-
tiplex Ligation-dependent Probe Amplification (MLPA)
technique to detect large deletions or duplications, and
sequencing of the entire genomic sequence of MEFV.
Results
We did not identify any mutations by sequencing MEFV
exons and splice sites, as well as putative regulatory
regions. Similarly, MLPA did not reveal any large dele-
tions or duplications within the genomic sequence of
MEFV. The sequencing of the entire genomic sequence
identified 20 different rare intronic variants that were
each identified in 1-3 affected individuals only, and were
not identified in about 700 ethnically matched control
chromosomes. The biological significance of these varia-
tions could not be determined.
Conclusion
It has been suggested that the reduced identification of
MEFV mutant alleles in Arabic patients is due to the
lack of application of a comprehensive mutation detec-
tion methodology. However, the current study negates
that hypothesis. We hypothesize that the current
sequencing technology produces a preferential amplifica-
tion of one allele over the other due to extensive poly-
morphism within the genomic sequence. To examine
this hypothesis we developed a parallel sequencing
approach for the genomic MEFV sequence. At this stage
of the study, we could not exclude the effect of modifier
genes or any other loci that influence the clinical picture
of FMF in Arabic populations.
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